BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Gene Logic

Gene Logic aims to be the drug development partner of choice for the pharmaceutical and biotechnology industries by providing a unique portfolio of drug discovery and development solutions. Our capabilities span the drug development pipeline and address some of the most important issues in drug development today - productivity, safety, and enhancing late-stage pipelines. Gene Logic two business units are: Drug Repositioning and Selection Genomics Services Through our Drug Repositioning and Selection™ (DRS™) Program, Gene Logic provides the pharmaceutical industry a unique cost-effective, low-risk partnering solution for finding new uses for their discontinued compounds, prioritizing the most promising lead candidates and finding the broadest therapeutic applications for a marketed compound lifecycle. Our partnerships are flexible, full service collaborations providing pharmaceutical companies the ability to share risk while working together to achieve success. Partners receive full access to our dedicated team of industry-leading drug developers and our comprehensive, multi-prong drug repositioning and selection technology platform. Pharmaceutical and biotechnology companies worldwide trust Gene Logic's proven portfolio of Genomics Services to help accelerate their drug development process. Utilizing our scientific expertise and genomics informatics capabilities, we have built a portfolio of gene reference and clinical database systems, software, toxicity consulting services, as well as gene expression and genotyping microarray data generation outsourcing services, designed to meet a variety of economic needs and support applications for: Microarray Reference Data Generation Gene Expression Profiling SNP Genotyping Data Analysis Services


Contact Details:
50 West Watkins Mill Road
Gaithersburg
MD
20878
United States of America
Tel:301.987.1700 or 800.GENELOGIC (800.436.3564)
Fax:301.987.1701
Email:info@genelogic.com.
WWW:

www.genelogic.com/




Loading...

Recent Publications by Gene Logic:

From pharmacogenomics to translational biomarkers.
There is a need for new biomarkers to enable faster detection of adverse...
2nd May, 2008
Department of Toxicogenomics, Gene Logic Inc., Gaithersburg, Maryland, Methods Mol Biol. 2008;460:195-220.
DOI Direct Link
In vivo predictive toxicogenomics.
Reference databases consisting of large sample numbers and...
2nd May, 2008
Department of Toxicogenomics, Gene Logic Inc., Gaithersburg, Maryland, Methods Mol Biol. 2008;460:113-43.
DOI Direct Link
Toxicogenomics and classic toxicology: how to improve prediction and mechanistic understanding of human toxicity.
The field of toxicogenomics has been advancing during the past decade or...
2nd May, 2008
Department of Toxicogenomics, Gene Logic Inc., Gaithersburg, Maryland, Methods Mol Biol. 2008;460:1-22.
DOI Direct Link
RNA--induced silencing of the plasma membrane Ca2+-ATPase 2 in neuronal cells: effects on Ca2+ homeostasis and cell viability.
Intraneuronal calcium ([Ca(2+)](i)) regulation is altered in aging brain,...
8th September, 2007
Gene Logic, Inc., Cambridge, Massachusetts, USA. J Neurochem. 2007 Jul;102(2):454-65. Epub 2007 May 4.
DOI Direct Link
Current trends and strategic directions in the use of pharmacogenomics to identify translational biomarkers.
The development of new drugs is hampered by the quality and usefulness of...
3rd April, 2007
Gene Logic Inc, Toxicogenomics, 610 Professional Drive, Gaithersburg, MD Curr Opin Drug Discov Devel. 2007 Jan;10(1):37-42.

View more Gene Logic research publications.

BioNews Results for Gene Logic:

Gene Logic renews agreement with Agilent Technologies
Pharmaceutical Business Review:  Jul 16 2008 5:41AM Matching: gene logic
Gene Logic Renews Agreement with Agilent Technologies as Certified Service Provider
DiGiTAL50:  Jul 15 2008 6:51AM Matching: gene logic
Agilent Renews Gene Logic's Status as Certified Microarray Service Provider
GenomeWeb:  Jul 14 2008 4:18PM Matching: gene logic
Targeting HDL in the Management of Mixed Dyslipidemia: Emerging Therapeutic Strategies for Cardiovascular Risk
Abstracts in Hematology and Oncology:  Jul 14 2008 9:22PM Matching: gene logic
Targeting HDL in the Management of Mixed Dyslipidemia: Emerging Therapeutic Strategies for Cardiovascular Risk
Medscape:  Jul 14 2008 8:41PM Matching: gene logic
Promote your company here: BioNewsCast - Press Release Distribution

View more Gene Logic news.

Gene Logic Patents:

US Patent No.Title
7321830 Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles
6109776 Method and system for computationally identifying clusters within a set of sequences
6130322 Coding sequences of the human BRCA1 gene
6312906 Immobilized nucleic acid hybridization reagent and method
6365352 Process to study changes in gene expression in granulocytic cells

View more Gene Logic patents.

Gene Logic (GLGC) Financial information Links from Barchart

GLGC Quote from from Barchart.com
GLGC Chart from from Barchart.com
GLGC Profile from from Barchart.com
GLGC Opinion from from Barchart.com

View more Gene Logic finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 423 times since April 2007, the link to the organisation's website has been followed 70 times

Recent Search Terms used to find this page: toxicogenomics,dr,email | Department of Toxicogenomics 50 West Watkins Mill Road Gaithersburg | drug repositioning publications | gene logic cambridge ma | Science and Engineering services INc MD site:bioportfolio com | 610 professional drive gaithersburg md | Gene Logic | drug reposition genomics platform | gene logic | Department of Toxicogenomics Services, Gene Logic, Inc., Gaithersburg, MD, USA | .

Search for more companies in Gaithersburg

Search for more companies in MD



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Gene Logic
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.